AI for OCT: Pathologies Detection
Comprehensive pathology detection and visualization of
biomarkers with our proprietorial AI algorithms.
Classification of over 70 biomarkers & pathologies and segmentations including early glaucoma, DR/DME, dAMD, nAMD, PED, epiretinal fibrosis, and CME.
Spend less time on OCT images, and more time on patient care and education with colour-coded segmentation.
The platform offers an interpretation of OCT in reports with customized measurements and selected biomarkers, retinal layers, or segments.
It also allows you to track changes in biomarkers of your choice over time for enhanced patient treatment and monitoring.
OCT analysis by Altris AI is implemented in 500+ modern eye clinics around the world and is used by thousands of eye care professionals.
- Empowerment of each eye care specialist with modern Artificial Intelligence tool that gives confidence;
- More effective triage of patients;
- Routine workflow optimisation;
- Making eye care business truly high-tech and profitable.
Altris AI is an artificial intelligence platform for OCT analysis that detects the widest range of retina pathologies and biomarkers on the market - more than 70. Leading the way in AI innovation, Altris AI provides transformative solutions that enhance the diagnosis, treatment, and monitoring of retinal diseases, enabling eye care professionals to deliver exceptional patient care.